Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
174 Leser
Artikel bewerten:
(0)

Sequent Medical Announces Closing of $26.0 Million Venture Financing

ALISO VIEJO, Calif., March 6, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $26.0 million Series C venture capital financing. Delphi Ventures led the financing and was joined by existing investors Versant Ventures, US Venture Partners, and Domain Associates. James Bochnowski of Delphi Ventures will join Sequent Medical's Board of Directors.

"We are fortunate to have a strong consortium of life science venture capital firms and would like to welcome both Delphi Ventures as an investor in Sequent Medical and James Bochnowski as a Board member," said Tom Wilder, President and Chief Executive Officer. "We will utilize these funds to support our clinical, commercial, and technology development programs, including our initial WEB® Aneurysm Embolization System product line." Building upon on the foundation of endovascular embolic coils, the WEB is an intrasaccular neurovascular embolization device that is designed to bridge the neck of a ruptured or unruptured intracranial aneurysm and to promote rapid, peri-procedural stasis.

About Sequent Medical, Inc.

Sequent Medical, Inc. is a neurovascular device company that is dedicated to the development of innovative catheter-based technologies for neurovascular specialists and their patients. The company has developed proprietary MicroBraid(TM) technology to create the WEB, a low porosity intrasaccular embolization device that is deployed within the aneurysm to facilitate occlusion and healing. The WEB bears the CE Mark, and is available at select centers in Europe and other countries, but is not available for use in the United States. Sequent Medical Inc. is headquartered in Aliso Viejo, California, and has a European operation based in Bonn, Germany. For more information, please visit www.sequentmedical.com.

SOURCE Sequent Medical, Inc.

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.